News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ZS Pharma To Present Data From Phase 3 Trial Of ZS-9 As Late-Breaking Oral Presentation At 2014 American Society of Hypertension (ASH) Annual Scientific Meeting


5/19/2014 6:41:07 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ZS Pharma, a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced that sub-group analysis data from a pivotal Phase 3 trial of ZS-9, an investigational treatment for hyperkalemia, will be presented as a late-breaking oral presentation at the 2014 American Society of Hypertension (ASH) Annual Scientific Meeting and Exposition at the New York Hilton Midtown in New York City.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES